saba

Research suggests opportunities to refine treatment guidelines and reduce unnecessary medication use. In the medical community, there is an ongoing debate over the Global Initiative for Asthma guidelines, which discourage the use of short-acting beta-agonists (SABAs) alone, in patients with mild asthma. Instead, the guidelines advise adding as needed anti-inflammatory therapy as a first step.…